ArticleCancer gene therapy2020

Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers.

Paula Barlabé et al.PubMed ↗Publisher ↗

No numbers read from the abstract.